Every year, more than 100 million refugees and displaced people live in overcrowded camps with little clean water, poor sanitation, and no access to regular healthcare. In these conditions, parasitic worms don’t just spread-they thrive. Hookworm, roundworm, whipworm, and pinworm infections are routine, not rare. Children lose weight. Mothers grow weak. Schools empty. And one cheap, simple drug-mebendazole-is often the only thing standing between a child and lifelong disability.
Parasitic infections aren’t dramatic like cholera outbreaks or measles epidemics. They don’t make headlines. But they slowly drain energy, stunt growth, and weaken immune systems. In refugee camps, where 30% to 70% of children test positive for soil-transmitted helminths, these worms are a hidden emergency.
People don’t always show symptoms at first. But over time, chronic infection leads to anemia from blood loss (hookworm), malnutrition because worms steal nutrients (roundworm), or even intestinal blockages (heavy whipworm loads). In kids, this means poor school performance, delayed development, and higher risk of dying from other illnesses.
Refugee camps are perfect breeding grounds. Shared latrines, bare feet on contaminated soil, lack of soap, and crowded living spaces mean eggs and larvae spread easily. A single infected child can contaminate an entire tent area within weeks.
Mebendazole is an anthelmintic drug. It works by blocking the worm’s ability to absorb glucose. Without sugar, the parasite starves and dies within days. It’s not a miracle cure-it doesn’t kill all worms instantly, and it doesn’t prevent re-infection. But it’s one of the most effective tools we have for reducing worm burden in mass settings.
It’s used against:
It doesn’t work on tapeworms, flukes, or protozoa like giardia. That’s why it’s never used alone in complex outbreaks-it’s part of a broader strategy. But for the most common worms in refugee settings, it’s the first-line choice.
There are alternatives: albendazole, pyrantel pamoate, ivermectin. So why do aid groups like WHO and UNHCR almost always pick mebendazole?
First, cost. A single 100mg tablet of mebendazole costs less than $0.05 in bulk. For a child, two tablets are enough. That’s $0.10 per treatment. For a camp of 5,000 children, that’s under $500 for a full round of deworming.
Second, safety. Mebendazole has been used for over 50 years. Side effects are rare and mild-maybe a stomach ache or dizziness in 1 in 100 people. It’s safe for children as young as one year old, pregnant women after the first trimester, and even people with HIV.
Third, ease of use. It doesn’t need refrigeration. No injections. No IV drips. Just swallow two tablets, one in the morning and one at night, or sometimes just a single dose. Community health workers can hand them out without medical training.
Albendazole is slightly more effective against hookworm, but it’s 30% more expensive and harder to source in bulk for low-income settings. In crisis zones, you don’t optimize for perfect-you optimize for possible.
Mass drug administration (MDA) isn’t random. It’s planned, tracked, and repeated.
First, NGOs and health ministries do rapid surveys. They collect stool samples from a sample of children. If over 20% test positive for worms, WHO recommends annual deworming. If it’s over 50%, they do it twice a year.
Then comes distribution. Teams go door-to-door in tents. They hand out pre-packed blister packs with two mebendazole tablets. Parents or older siblings give the dose. No need for a clinic. No waiting in line. No fear of needles.
Some programs use school-based delivery. In camps with makeshift schools, teachers distribute tablets during morning roll call. Kids get treated, then wash their hands with soap provided by the aid group.
After six months, they come back. Repeat. Because reinfection is inevitable. Clean water and toilets take years to build. Mebendazole buys time.
In the Cox’s Bazar refugee camps in Bangladesh, home to nearly a million Rohingya people, a 2023 study found that after two rounds of mebendazole distribution, worm infection rates dropped from 68% to 19% in children under five. School attendance rose by 22% in the following term.
In Uganda’s Bidibidi camp, where South Sudanese refugees live in extreme poverty, deworming with mebendazole led to a 35% increase in average weight gain among children under six over six months. That’s not just a number-it’s a child who can now play, learn, and survive.
One 2024 meta-analysis of 17 refugee and displacement settings found that regular mebendazole programs reduced anemia by 27% and improved cognitive test scores by 14% in children. These are not small gains. They’re life-changing.
It’s not all smooth. Some people refuse the tablets. They think worms are a normal part of life. Others worry about side effects, especially if they’ve heard myths-like mebendazole causes infertility or brain damage. Community leaders and local health workers spend weeks explaining the truth.
Logistics are brutal. Rain floods roads. Power cuts delay shipments. Customs hold up shipments for weeks. In Syria’s northwest, mebendazole shipments were delayed for four months during a blockade. Children kept getting infected. Aid workers had to split tablets to stretch supplies.
And yes, mebendazole doesn’t fix the root problem: dirty water, no toilets, no trash collection. But it’s the only tool we have right now that works fast, cheap, and at scale. Waiting for perfect conditions means waiting for children to die slowly.
Mebendazole isn’t a long-term solution. But it’s a bridge. While aid groups build latrines, train water engineers, and advocate for peace, mebendazole keeps children alive and learning. It gives them the strength to grow. To recover. To one day rebuild.
Every tablet is a small act of dignity. A child who isn’t dizzy from anemia can sit in class. A mother who isn’t weak from worms can carry water for her family. A teenager who isn’t constantly sick can start a trade.
In refugee health, we don’t always have vaccines, antibiotics, or surgeries. But we have mebendazole. And in the right hands, it does more than kill worms. It restores hope.
Yes, but only after the first trimester. WHO guidelines allow mebendazole for pregnant women in the second and third trimesters in areas with high rates of parasitic infection. The benefits of reducing anemia and improving maternal health outweigh the minimal risks. In crisis zones, untreated worm infections can lead to low birth weight and premature delivery-risks far greater than those from the drug.
No. Mebendazole is not recommended for children under 12 months. For infants, the focus is on preventing exposure-clean diapers, safe water, and hygiene education for caregivers. If a baby shows signs of infection, doctors may use alternative treatments like pyrantel pamoate, but only under direct medical supervision.
The World Health Organization recommends annual deworming if more than 20% of children are infected. In areas with over 50% infection rates, treatment is given twice a year-usually six months apart. This balances effectiveness with cost and logistics. In many camps, programs have shifted to biannual dosing because reinfection happens so quickly.
No. Mebendazole is effective against soil-transmitted helminths: roundworm, whipworm, hookworm, and pinworm. It does not work on tapeworms, flukes, or protozoan parasites like giardia or amoeba. In areas where these other infections are common, mebendazole is used alongside other drugs like praziquantel or metronidazole.
We do. But building clean water systems, latrines, and waste management takes years and millions of dollars. In active conflict zones or rapidly expanding camps, that’s not possible right now. Mebendazole is a stopgap that saves lives today while longer-term solutions are planned. It’s not either/or-it’s both/and.